MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

The NPPA rolls out new drug pricing regulations for 42 anti-cancer drugs

The NPPA rolls out new drug pricing regulations for 42 anti-cancer drugs

According to the announcement made by the National Pharmaceutical Pricing Authority, prices of 43 anti-cancer drugs will be regulated to curb the unwarranted profits made by chemists and drug stockists on various medicines. The NPAA, under the Drugs Control Act, 2013, has made price control changes in 36 types of medicines used in the treatment of blood pressure, cancer, diabetes, pain, asthma, etc. and now, it will take care of medicines for 38 rare diseases too.

Though the idea to regulate expensive cancer drugs had been in discussion for quite some time, the decision was put to effect on February 26.The new trade margins have been set to 30 percent for manufacturers which will be effective by March 8. This will ensure reduction in the prices of at least 72 medicine formulations containing the 42 drugs for which trade margin has been fixed. A senior doctor from the AIIMS said, “According to NPPA, after this decision, manufacturers of 105 cancer drugs will reduce profits up to 85 percent in the country. This will give cancer patients a benefit of about Rs 105 crore directly.

The regulators pointed out that the high trade margins are a major factor causing unreasonable price rise of drugs in India. Therefore, the regulators framed the order around eliminating the out-of-pocket expenditure on medicines that push people beyond the poverty threshold in the country. The regulators also said that many more actions will follow this move and target other medicines in the non-schedule category.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED